Literature DB >> 6711744

Cerebral cysticercosis: treatment with praziquantel. Report of two cases.

K Markwalder, K Hess, A Valavanis, F Witassek.   

Abstract

Two patients with cerebral cysticercosis are described: one with a long-standing infection with multiple intracerebral calcifications, and one who had become infected only recently. Treatment with praziquantel 50 mg/kg body weight daily for 14 days resulted in clinical and radiological improvement in the first patient, although she obviously still harbored a number of viable non-calcified parasites. The second patient was completely cured by the same praziquantel regimen. Both patients needed temporary corticosteroid treatment to suppress development of intracranial hypertension. Computerized tomographic scanning and regular measurement of serum antibody titers against cysticercal and echinococcal antigen seem appropriate methods for follow-up of the effect of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6711744     DOI: 10.4269/ajtmh.1984.33.273

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

1.  Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies.

Authors:  A Flisser; D Gonzalez; A Plancarte; P Ostrosky; R Montero; A Stephano; D Correa
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

2.  Cerebral cysticercosis in a European patient: problems of disease activity and therapeutic implications.

Authors:  A Thie; L Lachenmayer; R Bialek; K Kunze
Journal:  Klin Wochenschr       Date:  1987-05-15

3.  Effect of praziquantel on intraocular cysticercosis: a case report.

Authors:  P Kestelyn; H Taelman
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

Review 4.  Current consensus guidelines for treatment of neurocysticercosis.

Authors:  Hector H García; Carlton A W Evans; Theodore E Nash; Osvaldo M Takayanagui; A Clinton White; David Botero; Vedantam Rajshekhar; Victor C W Tsang; Peter M Schantz; James C Allan; Ana Flisser; Dolores Correa; Elsa Sarti; Jon S Friedland; S Manuel Martinez; Armando E Gonzalez; Robert H Gilman; Oscar H Del Brutto
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

5.  Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis.

Authors:  D Overbosch; J C van de Nes; E Groll; H W Diekmann; A M Polderman; H Mattie
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Diagnosis and treatment of neurocysticercosis.

Authors:  Christina M Coyle; Herbert B Tanowitz
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.